Medical devices

Keep requirements, risks and objective evidence connected.

Medical device teams must show that design outputs meet design inputs, the finished device satisfies user needs and intended uses, risk controls are verified, and production processes consistently achieve planned results. The strongest document chain preserves those relationships from planning through approval and change.

Industry application concept — device class, market and quality-system scope must be established with the customer.

Medical-device quality engineer comparing a device prototype with an engineering drawing

Where documentation concentrates

Evidence must answer a defined requirement or risk

Device documentation is most useful when plans, protocols, results and reports remain traceable to intended use, design inputs, critical characteristics and risk controls.

01

Design verification

Plans, methods, protocols and reports establish whether specified design outputs meet documented design inputs.

02

Design validation

Evidence addresses user needs and intended uses using production units or justified equivalents under defined conditions.

03

Risk management

Hazards, hazardous situations, risk controls, verification evidence and residual-risk conclusions remain connected.

04

Process validation

Protocols and reports support processes whose output cannot be fully verified by later monitoring or measurement.

05

Software assurance

Intended use and risk guide assurance activities for software used in production or the quality management system.

06

Usability and clinical evidence

Study plans and reports connect intended users, use environments, critical tasks, endpoints, observations and conclusions.

Representative lifecycle

From design input to approved evidence

Verification and validation are not interchangeable. The workflow should preserve the purpose and acceptance logic of each activity.

  1. Define intended use

    Users, environments, indications, claims and applicable requirements.

  2. Establish inputs and risks

    Design inputs, critical characteristics, hazards and risk controls.

  3. Plan the evidence

    Verification, validation, sampling, methods and acceptance criteria.

  4. Approve protocols

    Independent and qualified reviewers confirm readiness and traceability.

  5. Execute tests

    Record configurations, results, anomalies, deviations and source evidence.

  6. Evaluate and report

    Resolve discrepancies and document conclusions against requirements.

  7. Release and maintain

    Link evidence to the design history, change control and postmarket learning.

Source-to-output map

Traceability should survive document generation

The platform should help organize evidence without deciding whether a device is safe, effective, validated or releasable.

Typical source records

  • User needs and design inputs
  • System and subsystem requirements
  • Risk analyses and control measures
  • Drawings, specifications and software versions
  • Test methods, standards and sample rationale
  • Prior anomalies, changes and CAPA records

Controlled drafting support

  • Populate customer-approved plan and protocol structures
  • Carry requirement identifiers into test cases
  • Link risk controls to verification evidence
  • Preserve device configuration and source references
  • Expose missing criteria or unresolved anomalies
  • Record review, approval and disposition decisions

Governed outputs

  • Verification plan, protocol and report
  • Validation plan, protocol and report
  • Process validation package
  • Software assurance record
  • Usability or clinical study documentation
  • Traceability and evidence summaries
✓

Human decision boundary

Engineering, clinical, human-factors, software, quality and regulatory professionals define requirements, approve methods, evaluate anomalies, interpret evidence and authorize release. SmartX supports the document and traceability work surrounding those decisions.

Representative documents

Plan, execute, reconcile and retain

The exact record structure belongs to the manufacturer's quality management system.

Design controlsDesign and development plans, input/output reviews, verification and validation plans, protocols, reports and trace matrices.
Risk managementRisk-management plans and reports, hazard analyses, FMEAs, risk-control verification and benefit-risk documentation.
ManufacturingEquipment qualification, process validation, sterilization or packaging validation, test-method validation and inspection plans.
Software and systemsSoftware assurance plans and records, system requirements, test protocols, anomaly assessments and release evidence.
Lifecycle qualitySupplier qualification, nonconformance, CAPA, complaint investigation, change impact and revalidation assessments.

Accountable roles

Evidence crosses disciplines

Review routes should reflect the type of device, evidence and risk—not a generic approval list.

Systems and design engineeringIntended use, architecture, requirements, outputs and verification strategy.
Quality and regulatoryQMS controls, market requirements, independence, records and approval.
Manufacturing and supplier qualityProcess capability, equipment, validation, controls and external providers.
Clinical, usability and softwareSpecialized evidence for users, clinical performance, critical tasks and software behavior.

Critical reconciliation points

Evidence is useful only when configuration and traceability are explicit

A test result cannot close a requirement or risk control unless the tested article, software build, method and acceptance logic are the ones the approved plan intended.

01

Requirement and risk alignment

User needs, design inputs, hazards, risk controls and verification methods should form a visible chain, including the rationale for any requirement that is not directly tested.

02

Test configuration

Device revision, software build, accessories, fixtures, calibration status, environment, sample rationale and protocol deviation history must identify exactly what evidence was generated.

03

Anomaly and change closure

Failed tests, observations, unresolved anomalies, retesting, concessions and design changes should connect to documented disposition and updates to risk and traceability records.

→

Inputs for a focused medical-device pilot

Define the device family, classification, intended use and target markets; provide approved quality-system templates, one completed evidence chain, risk and traceability formats, source-system locations, naming and configuration rules, and the reviewer and release-authority matrix.

Primary reference points

Confirm the device, market and applicable standard

General educational information only. Device classification, intended use, market and organizational procedures determine applicability. References reviewed October 2026.

Evaluate one evidence chain

Start with one plan, its requirements and its completed test records.

A scoped pilot can test template fit, traceability and reviewer controls without changing the manufacturer's approval authority.

Request a workflow discussion